Picard Medical, Inc. 8-K

What Happened

• On March 12, 2026 Picard Medical, Inc. issued a press release announcing a webcasted Annual Business Update to be held March 25, 2026 at 4:30 p.m. Eastern Time. Management will review fiscal year and fourth quarter 2025 financial results and provide a business overview covering operational progress, commercial activity, and strategic priorities. The webcast will also include perspectives from leading clinicians and a patient testimonial about the SynCardia Total Artificial Heart.
• The press release (dated March 12, 2026) is furnished as Exhibit 99.1 to the 8-K and includes a registration link; the webcast registration is also available via the company website (www.picardmedical.com). The company notes the information is furnished under Regulation FD and is not “filed” for Exchange Act liability/incorporation purposes.

Key Details

• Press release issued: March 12, 2026.
• Webcast date/time: March 25, 2026 at 4:30 p.m. Eastern Time.
• Topics: review of FY and Q4 2025 financial results, operational progress, commercial activity, strategic priorities, clinician perspectives, and a patient testimonial regarding the SynCardia Total Artificial Heart.
• Registration: link in the press release (Exhibit 99.1) and on www.picardmedical.com.

Why It Matters

• Investors should view the webcast as the company’s formal update on recent quarterly and annual performance and its near-term commercial and operational plans—information that could affect expectations for future earnings and execution.
• The inclusion of clinician perspectives and a patient testimonial emphasizes focus on the SynCardia Total Artificial Heart product narrative, which can be relevant to assessments of commercial traction and market positioning.